2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
暂无分享,去创建一个
Simon Gibbs | Patrizio Lancellotti | Theresa McDonagh | Adam Torbicki | Marc Humbert | Maurice Beghetti | Georg Hansmann | Walter Klepetko | Gérald Simonneau | G. Hansmann | M. Humbert | A. Torbicki | W. Klepetko | P. Trindade | T. McDonagh | M. Zompatori | G. Simonneau | M. Hoeper | L. Pierard | P. Lancellotti | J. Vachiéry | I. Lang | A. Vonk Noordegraaf | M. Beghetti | Nazzareno Galiè | Andrew Peacock | Marius Hoeper | A. Peacock | Anton Vonk Noordegraaf | S. Gibbs | Irene Lang | Maurizio Zompatori | Pedro T. Trindade | N. Galiè | A. Ghofrani | M. G. Gómez Sánchez | M. Matucci | Jean-Luc Vachiery | Ardeschir Ghofrani | Miguel Angel Gomez Sanchez | Marco Matucci | Luc A. Pierard | J. Vachiéry
[1] M. Humbert,et al. Pulmonary veno-occlusive disease , 2016, European Respiratory Journal.
[2] Dave P. Miller,et al. Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)". , 2016, Circulation.
[3] J. Barberà,et al. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. , 2015, The New England journal of medicine.
[4] H. Ghofrani,et al. Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension , 2015, European Respiratory Journal.
[5] M. B. Bacchi Reggiani,et al. Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights , 2015, European Respiratory Journal.
[6] M. Humbert,et al. Criteria for diagnosis of exercise pulmonary hypertension , 2015, European Respiratory Journal.
[7] G. Simonneau,et al. Effect of Selexipag on Morbidity/Mortality in Pulmonary Arterial Hypertension: Results of the GRIPHON Study , 2015 .
[8] M. Humbert,et al. Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[9] E. Grünig,et al. PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension , 2015, European Respiratory Journal.
[10] A. Hanlon,et al. Development and initial psychometric properties of the Pulmonary Arterial Hypertension Symptom Scale (PAHSS). , 2015, Applied nursing research : ANR.
[11] M. Humbert,et al. Pulmonary arterial hypertension in patients treated with interferon , 2014, European Respiratory Journal.
[12] G. Lewis,et al. Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: limitations of a solitary measurement. , 2015, JACC. Heart failure.
[13] Thomas P Cappola,et al. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. , 2015, JACC. Heart failure.
[14] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[15] A. Swift,et al. CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry , 2014, Thorax.
[16] Fuqiang Wen,et al. CT-Base Pulmonary Artery Measurementin the Detection of Pulmonary Hypertension , 2014, Medicine.
[17] M. Humbert,et al. Update in systemic sclerosis-associated pulmonary arterial hypertension. , 2014, Presse medicale.
[18] M. Humbert,et al. Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group. , 2014, Presse medicale.
[19] R. Ciconelli,et al. Quality of life as a prognostic marker in pulmonary arterial hypertension , 2014, Health and Quality of Life Outcomes.
[20] M. Humbert,et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature , 2014, European Respiratory Journal.
[21] R. Naeije,et al. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. , 2014, American journal of respiratory and critical care medicine.
[22] S. Rosenkranz,et al. Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study. , 2014, International journal of cardiology.
[23] H. Hillege,et al. Identification of treatment goals in paediatric pulmonary arterial hypertension , 2014, European Respiratory Journal.
[24] J. Grapsa,et al. Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension. , 2014, Journal of the American College of Cardiology.
[25] M. Revel,et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism , 2014, Thrombosis and Haemostasis.
[26] Z. Jing,et al. Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients , 2014, European Respiratory Journal.
[27] S. Ghio,et al. Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. , 2014, Chest.
[28] T. Fukuda,et al. Organized thrombus in pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension; imaging with cone beam computed tomography , 2014, Japanese Journal of Radiology.
[29] B. Lipworth,et al. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial. , 2014, The Lancet. Respiratory medicine.
[30] R. Barst,et al. STARTS-2: Long-Term Survival With Oral Sildenafil Monotherapy in Treatment-Naive Pediatric Pulmonary Arterial Hypertension , 2014, Circulation.
[31] Angelo Branzi,et al. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. , 2014, European heart journal.
[32] M. Humbert,et al. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study , 2014, European Respiratory Journal.
[33] T. Fukuda,et al. Right ventricular reverse remodelling after balloon pulmonary angioplasty , 2014, European Respiratory Journal.
[34] D. Carroll,et al. Health-Related Quality of Life and Psychological States in Patients With Pulmonary Arterial Hypertension , 2014, The Journal of cardiovascular nursing.
[35] D. Kass,et al. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[36] J. Granton,et al. EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension. , 2014, American heart journal.
[37] W. Chung,et al. EIF2AK4 mutations in pulmonary capillary hemangiomatosis. , 2014, Chest.
[38] J. Wharton,et al. Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension. , 2014, Rheumatology.
[39] R. Speich,et al. Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA) , 2013, Circulation.
[40] H. Hillege,et al. Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre , 2014, Heart.
[41] D. Brodie,et al. Extracorporeal Membrane Oxygenation as a Novel Bridging Strategy for Acute Right Heart Failure in Group 1 Pulmonary Arterial Hypertension , 2014, ASAIO journal.
[42] J. Marcus,et al. Changes in Right Ventricular Function Measured by Cardiac Magnetic Resonance Imaging in Patients Receiving Pulmonary Arterial Hypertension–Targeted Therapy: The EURO-MR Study , 2014, Circulation. Cardiovascular imaging.
[43] J. Wild,et al. Prognostic Value of Cardiovascular Magnetic Resonance Imaging Measurements Corrected for Age and Sex in Idiopathic Pulmonary Arterial Hypertension , 2014, Circulation. Cardiovascular imaging.
[44] J. Newman,et al. High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension , 2014, Circulation. Heart failure.
[45] H. Heinzl,et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study , 2013, Annals of the rheumatic diseases.
[46] M. Humbert,et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension , 2013, Nature Genetics.
[47] J. Wilkinson,et al. Beta-adrenergic adaptation in idiopathic dilated cardiomyopathy: differences between children and adults. , 2014, European heart journal.
[48] S. Solomon,et al. GUIDELINES AND STANDARDS , 2010 .
[49] Toru Satoh,et al. Definitions and diagnosis of pulmonary hypertension. , 2013, Journal of the American College of Cardiology.
[50] W. Seeger,et al. Algorithm of Pulmonary Arterial Hypertension , 2022 .
[51] F. Martinez,et al. Pulmonary hypertension due to left heart diseases. , 2013, Journal of the American College of Cardiology.
[52] F. Martinez,et al. Pulmonary hypertension in chronic lung diseases. , 2013, Journal of the American College of Cardiology.
[53] G. Simonneau,et al. The Fifth World Symposium on Pulmonary Hypertension. , 2013, Journal of the American College of Cardiology.
[54] T. Fleming,et al. Pediatric pulmonary hypertension. , 2013, Journal of the American College of Cardiology.
[55] O. Sitbon,et al. Treatment goals of pulmonary hypertension. , 2013, Journal of the American College of Cardiology.
[56] P. Ferrari,et al. Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives , 2013, European Respiratory Review.
[57] A. Peacock,et al. Cardiac magnetic resonance imaging in pulmonary arterial hypertension , 2013, European Respiratory Review.
[58] T. Lahm,et al. World Health Organization group 5 pulmonary hypertension. , 2013, Clinics in chest medicine.
[59] M. Humbert,et al. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. , 2013, Arthritis and rheumatism.
[60] P. Corris,et al. emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension , 2013, European Respiratory Journal.
[61] I. Susanto,et al. Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients , 2013, Case reports in pulmonology.
[62] C. Fischer,et al. Assessment and Prognostic Relevance of Right Ventricular Contractile Reserve in Patients With Severe Pulmonary Hypertension , 2013, Circulation.
[63] A. Morton,et al. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry. , 2013, JACC. Cardiovascular imaging.
[64] G. Coghlan. Does left heart disease cause most systemic sclerosis associated pulmonary hypertension? , 2013, European Respiratory Journal.
[65] R. Speich,et al. Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease. , 2013, International journal of cardiology.
[66] W. Klepetko,et al. Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy , 2013, Thorax.
[67] A. Manes,et al. New treatment strategies for pulmonary arterial hypertension: hopes or hypes? , 2013, Journal of the American College of Cardiology.
[68] G. Stone,et al. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension). , 2013, Journal of the American College of Cardiology.
[69] G. Hansmann,et al. Registries for paediatric pulmonary hypertension , 2013, European Respiratory Journal.
[70] M. Hoeper,et al. Atrial flutter and fibrillation in patients with pulmonary hypertension. , 2013, International journal of cardiology.
[71] E. Wang,et al. Role of Pretransplant Echocardiographic Evaluation in Predicting Outcomes Following Liver Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[72] P. Pellikka,et al. Outcome Prediction by Quantitative Right Ventricular Function Assessment in 575 Subjects Evaluated for Pulmonary Hypertension , 2013, Circulation. Cardiovascular imaging.
[73] Z. Jing,et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. , 2013, The New England journal of medicine.
[74] R. Hetzer,et al. Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. , 2013, International journal of cardiology.
[75] N. Westerhof,et al. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses , 2013, European Respiratory Journal.
[76] Amit R. Patel,et al. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension. , 2013, International journal of cardiology.
[77] B. Borlaug,et al. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. , 2013, JACC. Heart failure.
[78] H. Ghofrani,et al. Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction: A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic Study , 2013, Circulation.
[79] W. Chung,et al. A novel channelopathy in pulmonary arterial hypertension. , 2013, The New England journal of medicine.
[80] M. Humbert,et al. Riociguat for the treatment of pulmonary arterial hypertension. , 2013, The New England journal of medicine.
[81] Chen Wang,et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. , 2013, The New England journal of medicine.
[82] A. Ragnarsson,et al. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension , 2013, Heart.
[83] K. Fukuda,et al. Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. , 2013, JACC. Cardiovascular interventions.
[84] N. Rothfield,et al. Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients , 2013, The clinical respiratory journal.
[85] R. Barst,et al. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry. , 2013, Chest.
[86] M. Arzt,et al. Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension , 2013, European journal of heart failure.
[87] G. Karatasakis,et al. Complications Leading to Sudden Cardiac Death in Pulmonary Arterial Hypertension , 2013, Respiratory Care.
[88] A. Torbicki,et al. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension , 2013, Thrombosis and Haemostasis.
[89] L. Pacheco,et al. Management of pulmonary arterial hypertension during pregnancy: a retrospective, multicenter experience. , 2013, Chest.
[90] L. Chan,et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. , 2013, Respiratory medicine.
[91] J. Feinstein,et al. Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice , 2013, European Respiratory Journal.
[92] J. Lock,et al. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[93] R. Naeije,et al. Chronic thromboembolic pulmonary hypertension: role of medical therapy , 2013, European Respiratory Journal.
[94] C. Denton,et al. Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension. , 2013, Arthritis and rheumatism.
[95] A. Geerts,et al. Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation , 2013, European journal of gastroenterology & hepatology.
[96] Y. Boudjemline,et al. Patent Ductus Arteriosus Stenting (Transcatheter Potts Shunt) for Palliation of Suprasystemic Pulmonary Arterial Hypertension: A Case Series , 2013, Circulation. Cardiovascular interventions.
[97] W. Fang,et al. [A comparison of ventilation/perfusion single photon emission CT and CT pulmonary angiography for diagnosis of pulmonary embolism]. , 2013, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
[98] Yuhui Zhang,et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. , 2013, Chest.
[99] J. Barberà,et al. Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial , 2013, European Respiratory Journal.
[100] Z. Jing,et al. Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled Trial , 2013, Circulation.
[101] L. Chan,et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. , 2013, Chest.
[102] H. Olschewski,et al. Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension. , 2013, Chest.
[103] H. Marshall,et al. 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry , 2013, Thorax.
[104] M. Humbert,et al. Chronic thromboembolic pulmonary hypertension: advances from bench to patient management , 2013, European Respiratory Journal.
[105] B. Levine,et al. Hemodynamic Responses to Rapid Saline Loading: The Impact of Age, Sex, and Heart Failure , 2013, Circulation.
[106] R. Barst,et al. Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee , 2013, Pulmonary circulation.
[107] M. Humbert,et al. Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era , 2012, Annals of the rheumatic diseases.
[108] Horst Olschewski,et al. Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[109] Vittorio Pengo,et al. Chronic thromboembolic pulmonary hypertension. , 2006, Journal of the American College of Cardiology.
[110] M. Humbert,et al. High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms. , 2013, Chest.
[111] M. Humbert,et al. Pulmonary arterial hypertension: epidemiology and registries. , 2013, Journal of the American College of Cardiology.
[112] Dave P. Miller,et al. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry. , 2013, Chest.
[113] M. Hudson,et al. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension , 2012, European Respiratory Journal.
[114] J. Newman,et al. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.
[115] J. Vachiéry,et al. Challenges in the diagnosis and treatment of pulmonary arterial hypertension , 2012, European Respiratory Review.
[116] A. Torbicki,et al. Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension. , 2012, Chest.
[117] E. Castañer,et al. Imaging findings in pulmonary vasculitis. , 2012, Seminars in ultrasound, CT, and MR.
[118] D. Badesch,et al. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. , 2012, Chest.
[119] M. Ando,et al. Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension , 2012, Circulation. Cardiovascular interventions.
[120] A. Ogawa,et al. Refined Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension , 2012, Circulation. Cardiovascular interventions.
[121] T. Fleming,et al. Biomarkers and surrogate endpoints in clinical trials , 2012, Statistics in medicine.
[122] M. Humbert,et al. Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey , 2012, European Respiratory Journal.
[123] R. Naeije,et al. Echocardiography of pulmonary vascular function in asymptomatic carriers of BMPR2 mutations , 2012, European Respiratory Journal.
[124] M. Humbert,et al. Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies. , 2012, Chest.
[125] S. Rich,et al. Noninvasive cardiac output measurements in patients with pulmonary hypertension , 2012, European Respiratory Journal.
[126] Jeff A Sloan,et al. Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[127] A. Rahmel,et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[128] O. Alfieri,et al. Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.
[129] J. Wild,et al. Pulmonary hypertension in COPD: results from the ASPIRE registry , 2012, European Respiratory Journal.
[130] P. Gargiulo,et al. Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials. , 2012, Journal of the American College of Cardiology.
[131] R. Speich,et al. The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) , 2012, Health and Quality of Life Outcomes.
[132] M. Humbert,et al. Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. , 2012, Arthritis and rheumatism.
[133] R. Benza,et al. World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[134] T. Welte,et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. , 2012, American journal of respiratory and critical care medicine.
[135] R. Naeije,et al. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease , 2012, European Respiratory Journal.
[136] M. Guazzi,et al. Pulmonary Hypertension Due to Left Heart Disease , 2012, Circulation.
[137] M. Madani,et al. Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. , 2012, The Annals of thoracic surgery.
[138] T. De Marco,et al. Pulmonary hypertension associated with left-sided heart disease. , 2012, Heart failure clinics.
[139] E. Milne. Forgotten gold in diagnosing pulmonary hypertension: the plain chest radiograph. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.
[140] Jim M Wild,et al. Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry , 2012, Journal of Cardiovascular Magnetic Resonance.
[141] C. Fischer,et al. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases , 2012, Arthritis Research & Therapy.
[142] J. Yuan,et al. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding , 2012, European Respiratory Journal.
[143] A. Munnich,et al. Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation , 2012, European Respiratory Journal.
[144] M. Humbert,et al. Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension , 2012, European Respiratory Journal.
[145] M. Bartels,et al. Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial , 2012, COPD.
[146] W. Fang,et al. Diagnosis of chronic thromboembolic pulmonary hypertension: comparison of ventilation/perfusion scanning and multidetector computed tomography pulmonary angiography with pulmonary angiography , 2012, Nuclear medicine communications.
[147] M. Humbert,et al. Résultats tardifs de la commissurotomie mitrale percutanée à 20 ans Création et validation d ’ un score de risque prédisant les résultats fonctionnels à long terme à partir d ’ une série de 912 patients , 2012 .
[148] H. Palevsky,et al. Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials , 2012, Circulation.
[149] M. Humbert,et al. Pulmonary hypertension associated with benfluorex exposure , 2012, European Respiratory Journal.
[150] J. Yorke,et al. The trajectory to diagnosis with pulmonary arterial hypertension: a qualitative study , 2012, BMJ Open.
[151] R. Dweik,et al. Portopulmonary hypertension: a report from the US-based REVEAL Registry. , 2012, Chest.
[152] S. Keshavjee,et al. Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience. , 2012, The Journal of thoracic and cardiovascular surgery.
[153] L. Farkas,et al. Severe pulmonary hypertension: The role of metabolic and endocrine disorders , 2012, Pulmonary circulation.
[154] R. Steinhorn,et al. Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents. , 2012, Clinics in perinatology.
[155] M. Madani,et al. State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management , 2012, European Respiratory Review.
[156] A. Torbicki,et al. Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension , 2012, European Respiratory Journal.
[157] J. Barberà,et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry , 2012, European Respiratory Journal.
[158] G. Raskob,et al. Clinical features of paediatric pulmonary hypertension: a registry study , 2012, The Lancet.
[159] R. Speich,et al. Safety and efficacy of exercise training in various forms of pulmonary hypertension , 2012, European Respiratory Journal.
[160] M. Humbert,et al. Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[161] Z. Jing,et al. Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension. , 2012, Chest.
[162] M. Humbert,et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era , 2012, European Respiratory Journal.
[163] V. Roger,et al. Pulmonary pressures and death in heart failure: a community study. , 2012, Journal of the American College of Cardiology.
[164] R. Barst,et al. A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension , 2012, Circulation.
[165] R. Barst,et al. Survival in Childhood Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management , 2011, Circulation.
[166] D. Ivy,et al. Initial Experience With Tadalafil in Pediatric Pulmonary Arterial Hypertension , 2011, Pediatric Cardiology.
[167] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[168] D. Badesch,et al. ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension. , 2009, Cardiovascular therapeutics.
[169] A. Branzi,et al. Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger’s Syndrome , 2012, Drugs.
[170] H. Shimokawa,et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[171] H. Marshall,et al. Black blood MRI has diagnostic and prognostic value in the assessment of patients with pulmonary hypertension , 2012, European Radiology.
[172] S. Ley,et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH) , 2012, European Radiology.
[173] Shengshou Hu,et al. Combination Therapy in Pulmonary Arterial Hypertension: A Meta-Analysis , 2011, Cardiology.
[174] V. Russo,et al. Extensive right pulmonary artery dissection in a young patient with chronic pulmonary hypertension , 2011, Heart.
[175] Nico Westerhof,et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. , 2011, Journal of the American College of Cardiology.
[176] W. Haefeli,et al. Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011. , 2011, International journal of cardiology.
[177] J. Granton,et al. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. , 2011, American journal of respiratory and critical care medicine.
[178] A. Wells,et al. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests. , 2011, Arthritis and rheumatism.
[179] M. Humbert,et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. , 2011, Arthritis and rheumatism.
[180] A. Klein,et al. Extracorporeal membrane oxygenation as a bridge to pulmonary endarterectomy. , 2011, The Annals of thoracic surgery.
[181] J. Barberà,et al. Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry , 2011, Circulation.
[182] M. de Pauw,et al. Iron deficiency is associated with adverse outcome in Eisenmenger patients. , 2011, European heart journal.
[183] T. Delhaas,et al. Pediatric Pulmonary Hypertension in the Netherlands: Epidemiology and Characterization During the Period 1991 to 2005 , 2011, Circulation.
[184] L. Sharples,et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial , 2011, The Lancet.
[185] S. Keshavjee,et al. Impact of extracorporeal life support on outcome in patients with idiopathic pulmonary arterial hypertension awaiting lung transplantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[186] T. Welte,et al. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension , 2011, European Respiratory Journal.
[187] M. Humbert,et al. Ventilation/perfusion lung scan in pulmonary veno-occlusive disease , 2011, European Respiratory Journal.
[188] R. Ewert,et al. Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension. , 2011, Zeitschrift fur Gastroenterologie.
[189] V. Salemi,et al. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease , 2011, European Respiratory Journal.
[190] J. Wharton,et al. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. , 2011, Journal of the American College of Cardiology.
[191] L. Savale,et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. , 2011, The New England journal of medicine.
[192] Z. Jing,et al. Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study. , 2011, American journal of respiratory and critical care medicine.
[193] J. Grapsa,et al. Right atrial flutter isthmus ablation is feasible and results in acute clinical improvement in patients with persistent atrial flutter and severe pulmonary arterial hypertension. , 2011, International journal of cardiology.
[194] P. Pellikka,et al. Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. , 2011, Chest.
[195] H. Haller,et al. Osteopontin in patients with idiopathic pulmonary hypertension. , 2011, Chest.
[196] E. Rosenzweig,et al. Ambrisentan for pulmonary arterial hypertension due to congenital heart disease. , 2011, The American journal of cardiology.
[197] Sanjiv J. Shah,et al. Clinical Characteristics of Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction , 2011, Circulation. Heart failure.
[198] D. Celermajer,et al. Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension. , 2011, The Journal of pediatrics.
[199] S. Harikrishnan,et al. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011 , 2011, Pulmonary circulation.
[200] D. Ivy,et al. Pulmonary arterial hypertension: a comparison between children and adults , 2011, European Respiratory Journal.
[201] A. Torbicki,et al. Recurrent hemoptysis: an emerging life-threatening complication in idiopathic pulmonary arterial hypertension. , 2011, Chest.
[202] M. Madani,et al. Chronic thromboembolic pulmonary hypertension in pediatric patients. , 2011, The Journal of thoracic and cardiovascular surgery.
[203] W. Klepetko,et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. , 2011, The Journal of thoracic and cardiovascular surgery.
[204] L. Stevenson,et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.
[205] S. Rosenkranz,et al. Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension , 2011, Respiration.
[206] R. Naeije,et al. Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension. , 2011, British journal of clinical pharmacology.
[207] Rami Dhillon. The management of neonatal pulmonary hypertension , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[208] M. Humbert,et al. Pulmonary veno-occlusive disease: the bête noire of pulmonary hypertension in connective tissue diseases? , 2011, Presse medicale.
[209] I. Schulze-Neick,et al. Issues related to the management and therapy of paediatric pulmonary hypertension , 2010, European Respiratory Review.
[210] G. Maurer,et al. Imaging in pulmonary hypertension. , 2010, JACC. Cardiovascular imaging.
[211] J. Cracowski,et al. Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies , 2010, The Journal of Rheumatology.
[212] S. Ghio,et al. Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis , 2010, Heart.
[213] S. Ghio,et al. Comparison of Brain Natriuretic Peptide (BNP) and NT-proBNP in Screening for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis , 2010, The Journal of Rheumatology.
[214] Seung‐Jung Park,et al. Left main coronary artery compression from pulmonary artery enlargement due to pulmonary hypertension: A contemporary review and argument for percutaneous revascularization , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[215] N. Westerhof,et al. Iron deficiency is common in idiopathic pulmonary arterial hypertension , 2010, European Respiratory Journal.
[216] S. Brett,et al. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review , 2010, Critical care.
[217] Takahiro Shiota,et al. Accuracy of right ventricular volumes and function determined by three-dimensional echocardiography in comparison with magnetic resonance imaging: a meta-analysis study. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[218] T. Welte,et al. Extracorporeal Membrane Oxygenation in Nonintubated Patients as Bridge to Lung Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[219] A. Chapelier,et al. Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[220] M. Hoeper,et al. Circulating angiopoietins in idiopathic pulmonary arterial hypertension. , 2010, European heart journal.
[221] R. Nishimura,et al. Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction , 2010, Circulation. Heart failure.
[222] Qi Fu,et al. Characterization of Static and Dynamic Left Ventricular Diastolic Function in Patients With Heart Failure With a Preserved Ejection Fraction , 2010, Circulation. Heart failure.
[223] H. Collard,et al. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. , 2010, The New England journal of medicine.
[224] H. Heinzl,et al. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension , 2010, European Respiratory Journal.
[225] M. Humbert,et al. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. , 2010, European heart journal.
[226] Christopher S Coffey,et al. Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.
[227] M. Humbert,et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension , 2010, European Respiratory Journal.
[228] A. Manes,et al. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses , 2010, European heart journal.
[229] Horst Olschewski,et al. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. , 2010, Journal of the American College of Cardiology.
[230] K. Iversen,et al. Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. , 2010, European heart journal.
[231] M. Humbert,et al. Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era , 2010, Circulation.
[232] I. Schulze-Neick,et al. Childhood idiopathic pulmonary arterial hypertension: a national cohort study , 2010, Heart.
[233] R. Arena,et al. Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[234] L. Shapiro,et al. Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[235] J. Barberà,et al. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. , 2010, American journal of respiratory and critical care medicine.
[236] M. Loebe,et al. Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[237] M. Humbert,et al. Pulmonary hypertension in patients with chronic myeloproliferative disorders , 2010, European Respiratory Journal.
[238] M. Humbert,et al. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era , 2010, AIDS.
[239] H. Tan,et al. Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. , 2010, The Journal of thoracic and cardiovascular surgery.
[240] Sanjiv J. Shah,et al. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation , 2009, European Respiratory Journal.
[241] R. Barst,et al. Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study , 2009, British journal of clinical pharmacology.
[242] M. Humbert,et al. Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension , 2009, European Respiratory Journal.
[243] A. Borczuk,et al. Sarcoidosis-Associated Fibrosing Mediastinitis with Resultant Pulmonary Hypertension: A Case Report and Review of the Literature , 2009, Respiration.
[244] N. Westerhof,et al. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension , 2009, European Respiratory Journal.
[245] J. Vachiéry,et al. Screening for pulmonary arterial hypertension in systemic sclerosis , 2009, European Respiratory Review.
[246] M. Rubenfire,et al. Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: an unmet need. , 2009, Chest.
[247] M. Humbert,et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome , 2009, European Respiratory Journal.
[248] S. Halpern,et al. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. , 2009, Chest.
[249] J. Newman,et al. Association of the metabolic syndrome with pulmonary venous hypertension. , 2009, Chest.
[250] H. Palevsky,et al. Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension. , 2009, Mayo Clinic proceedings.
[251] M. Galanski,et al. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. , 2009, European journal of radiology.
[252] M. Maitland,et al. Inflammation, growth factors, and pulmonary vascular remodeling. , 2009, Journal of the American College of Cardiology.
[253] Horst Olschewski,et al. Diagnosis and assessment of pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.
[254] N. Weissmann,et al. Cellular and molecular basis of pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.
[255] P. Corris,et al. Interventional and surgical modalities of treatment in pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[256] W. Chung,et al. [Genetics and genomics of pulmonary arterial hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[257] M. Humbert,et al. Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease , 2009, European Respiratory Journal.
[258] B. Brundage,et al. Tadalafil Therapy for Pulmonary Arterial Hypertension , 2009, Circulation.
[259] J. Butler,et al. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. , 2009, American heart journal.
[260] Z. Jing,et al. Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension , 2009, European Respiratory Journal.
[261] M. D. de Vera,et al. Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end‐stage liver disease , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[262] Patrick W O'Leary,et al. Measurement, interpretation and use of hemodynamic parameters , 2009, Cardiology in the Young.
[263] H. Tighiouart,et al. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. , 2009, American journal of respiratory and critical care medicine.
[264] T. Nawrot,et al. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.
[265] M. Corretti,et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. , 2009, American journal of respiratory and critical care medicine.
[266] T. Welte,et al. Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist Device , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[267] A Berghold,et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review , 2009, European Respiratory Journal.
[268] M. Beghetti,et al. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.
[269] M. Humbert,et al. Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension: Results of a Multicenter European Analysis of Pulmonary Artery Pressure Response to Exercise and Hypoxia , 2009, Circulation.
[270] P. Corris,et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. , 2009, American journal of respiratory and critical care medicine.
[271] M. Humbert,et al. Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study , 2008, Rheumatology.
[272] A. Branzi,et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension , 2008, European heart journal.
[273] D. Badesch,et al. Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities. , 2006, Chest.
[274] A. Torbicki,et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. , 2008, Journal of the American College of Cardiology.
[275] G. Dadlani,et al. Echocardiography in tetralogy of Fallot , 2008, Cardiology in the Young.
[276] R. Wiesner,et al. Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[277] S. Stavropoulos,et al. Digital subtraction pulmonary arteriography versus multidetector CT in the detection of pulmonary arteriovenous malformations. , 2008, Journal of vascular and interventional radiology : JVIR.
[278] T. Fleming,et al. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension (Annals of Internal Medicine (2008) 149 (521-530)) , 2008 .
[279] T. Fleming,et al. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. , 2008, Annals of internal medicine.
[280] M. Zenati,et al. Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. , 2008, The Annals of thoracic surgery.
[281] A. Vuylsteke,et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. , 2008, The Annals of thoracic surgery.
[282] H. Palevsky,et al. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. , 2008, Respiratory medicine.
[283] M. Humbert,et al. Portopulmonary hypertension: survival and prognostic factors. , 2008, American journal of respiratory and critical care medicine.
[284] F. Laenger,et al. Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.
[285] M. Tamm,et al. A randomised, controlled trial of bosentan in severe COPD , 2008, European Respiratory Journal.
[286] S. Nathan,et al. Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. , 2008, Respiratory medicine.
[287] Ashish S Shah,et al. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. , 2008, The Annals of thoracic surgery.
[288] P. Thomas,et al. Biomarkers in pulmonary hypertension , 2008, European Respiratory Journal.
[289] M. Humbert,et al. Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension , 2008, European Respiratory Journal.
[290] J. Trotter,et al. Clinical risk factors for portopulmonary hypertension , 2008, Hepatology.
[291] R. Benza,et al. Guidelines for the prevention of central venous catheter‐related blood stream infections with prostanoid therapy for pulmonary arterial hypertension , 2008, International journal of clinical practice. Supplement.
[292] M. Humbert,et al. Pulmonary Veno-Occlusive Disease: Clinical, Functional, Radiologic, and Hemodynamic Characteristics and Outcome of 24 Cases Confirmed by Histology , 2008, Medicine.
[293] M. Gatzoulis,et al. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. , 2008, International journal of cardiology.
[294] G. Simonneau,et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial , 2008, The Lancet.
[295] B. Wiens,et al. Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2 , 2008, Circulation.
[296] M. Heneghan,et al. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[297] M. Manns,et al. Indications for and Outcomes After Combined Lung and Liver Transplantation: A Single-Center Experience on 13 Consecutive Cases , 2008, Transplantation.
[298] G. MacGowan,et al. Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland , 2008, Heart.
[299] M. Gómez,et al. Estándares asistenciales en hipertensión pulmonar , 2008 .
[300] I. Schulze-Neick,et al. Classifying pulmonary hypertension in the setting of the congenitally malformed heart – cleaning up a dog’s dinner , 2008, Cardiology in the Young.
[301] R. Berger,et al. Pulmonary arterial hypertension in congenital cardiac disease – the need for refinement of the Evian-Venice classification , 2008, Cardiology in the Young.
[302] M. Humbert,et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. , 2008, Arthritis and rheumatism.
[303] R. Barst,et al. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. , 2008, Journal of the American College of Cardiology.
[304] G. Baumann,et al. Long-term follow-up of a fenestrated Amplatzer atrial septal occluder in pulmonary arterial hypertension. , 2007, Chest.
[305] Y. Allanore,et al. Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials , 2007, Annals of the rheumatic diseases.
[306] M. Mitchell,et al. Pharmacokinetic Interaction Between Tadalafil and Bosentan in Healthy Male Subjects , 2006, Journal of clinical pharmacology.
[307] D. Borderie,et al. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. , 2008, Arthritis and rheumatism.
[308] G. Simonneau,et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. , 2008, American journal of respiratory and critical care medicine.
[309] J. Barberà,et al. Standards of care in pulmonary hypertension. , 2008, Revista espanola de cardiologia.
[310] T. Welte,et al. Experience with inhaled iloprost and bosentan in portopulmonary hypertension , 2007, European Respiratory Journal.
[311] R. Naeije,et al. Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? , 2007, European Respiratory Journal.
[312] W. Seeger,et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension , 2007, European Respiratory Journal.
[313] P. Postmus,et al. Cardiopulmonary Exercise Test Characteristics in Patients with Chronic Obstructive Pulmonary Disease and Associated Pulmonary Hypertension , 2007, Respiration.
[314] F. Haddad,et al. Management strategies for patients with pulmonary hypertension in the intensive care unit* , 2007, Critical care medicine.
[315] M. Rubens,et al. Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. , 2007, Journal of the American College of Cardiology.
[316] M. Humbert,et al. Results of European post-marketing surveillance of bosentan in pulmonary hypertension , 2007, European Respiratory Journal.
[317] J. McMurray,et al. An epidemiological study of pulmonary arterial hypertension , 2007, European Respiratory Journal.
[318] A. Lammers,et al. Epoprostenol treatment in children with severe pulmonary hypertension , 2006, Heart.
[319] P. Engelfriet,et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease , 2006, Heart.
[320] T. Welte,et al. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension , 2007, European Respiratory Journal.
[321] G. Klintmalm,et al. The Impact of Treatment of Portopulmonary Hypertension on Survival Following Liver Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[322] P. Gishen,et al. Ventilation–Perfusion Scintigraphy Is More Sensitive than Multidetector CTPA in Detecting Chronic Thromboembolic Pulmonary Disease as a Treatable Cause of Pulmonary Hypertension , 2007, Journal of Nuclear Medicine.
[323] J. Bronzwaer,et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. , 2007, European heart journal.
[324] Grzegorz Opolski,et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. , 2007, Chest.
[325] M. Humbert,et al. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[326] W. Klepetko,et al. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension , 2007, Journal of thrombosis and haemostasis : JTH.
[327] R. Oudiz. Pulmonary hypertension associated with left-sided heart disease. , 2007, Clinics in chest medicine.
[328] G. Diller,et al. Pulmonary Vascular Disease in Adults With Congenital Heart Disease , 2007, Circulation.
[329] B. Hartmann,et al. N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension. , 2007, Chest.
[330] M. Humbert,et al. Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension , 2007, Journal of cardiovascular pharmacology.
[331] K. Kerr,et al. Chronic thromboembolic pulmonary hypertension. , 2001, Clinics in chest medicine.
[332] M. Hoeper,et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. , 2007, American heart journal.
[333] Z. Jing,et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. , 2006, Journal of the American College of Cardiology.
[334] P. Thistlethwaite,et al. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. , 2006, The Annals of thoracic surgery.
[335] R. Wiesner,et al. Portopulmonary hypertension: Results from a 10‐year screening algorithm , 2006, Hepatology.
[336] R. Barst,et al. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. , 2006, American journal of respiratory and critical care medicine.
[337] T. Abraham,et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.
[338] M. Gupta,et al. Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome: A Preliminary Observational Study , 2006, Circulation.
[339] F. Herth,et al. Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension , 2006, Circulation.
[340] M. Hoeper,et al. Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension , 2006, European Respiratory Journal.
[341] R. Speich,et al. Measurement of quality of life in pulmonary hypertension and its significance , 2006, European Respiratory Journal.
[342] Nazzareno Galiè,et al. Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension. , 2006, Proceedings of the American Thoracic Society.
[343] W. Klepetko,et al. Current and future management of chronic thromboembolic pulmonary hypertension: from diagnosis to treatment responses. , 2006, Proceedings of the American Thoracic Society.
[344] J. Krishnan,et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. , 2006, Arthritis and rheumatism.
[345] W. Seeger,et al. Sildenafil treatment for portopulmonary hypertension , 2006, European Respiratory Journal.
[346] Marshall I Hertz,et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[347] G. Barbarini,et al. Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension , 2006, Heart.
[348] M. Gatzoulis,et al. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. , 2006, Journal of the American College of Cardiology.
[349] M. Gatzoulis,et al. Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study , 2006, Circulation.
[350] A. Nicholson,et al. Pulmonary Veno-occlusive Disease and Pulmonary Capillary Hemangiomatosis: A Clinicopathologic Study of 35 Cases , 2006, The American journal of surgical pathology.
[351] N. Rothfield,et al. Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma. , 2006, Chest.
[352] M. Humbert,et al. The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study , 2006, European Respiratory Journal.
[353] C. Denton,et al. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. , 2006, European heart journal.
[354] A. Torbicki,et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. , 2006, Chest.
[355] M. Humbert,et al. Pulmonary arterial hypertension in France: results from a national registry. , 2006, American journal of respiratory and critical care medicine.
[356] N. Panay,et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension , 2006, Journal of Family Planning and Reproductive Health Care.
[357] M. Peberdy,et al. Prognostic value of heart rate recovery in patients with heart failure. , 2006, American heart journal.
[358] S. Malhotra,et al. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. , 2006, American heart journal.
[359] S. Nathan,et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. , 2006, Chest.
[360] R. Benza,et al. Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial. , 2006, Chest.
[361] M. Humbert,et al. Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. , 2006, European heart journal.
[362] M. Humbert,et al. Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension , 2006, European Respiratory Journal.
[363] M. Humbert,et al. Occult alveolar haemorrhage in pulmonary veno-occlusive disease , 2006, European Respiratory Journal.
[364] J. Loscalzo,et al. Pulmonary arterial hypertension. , 2004, Annals of medicine.
[365] M. Humbert,et al. Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension. , 2006, Gastroenterology.
[366] D. Meads,et al. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): A Measure of Health-Related Quality of Life and Quality of Life for Patients with Pulmonary Hypertension , 2006, Quality of Life Research.
[367] M. Humbert,et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. , 2005, Arthritis and rheumatism.
[368] T. Fleming,et al. Sildenafil citrate therapy for pulmonary arterial hypertension. , 2005, The New England journal of medicine.
[369] G. Derrick,et al. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension , 2005, Heart.
[370] M. Kramer,et al. Pregnancy Outcome in Patients With Pulmonary Arterial Hypertension Receiving Prostacyclin Therapy , 2005, Obstetrics and gynecology.
[371] T. Welte,et al. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension , 2005, European Respiratory Journal.
[372] J. Hankinson,et al. Interpretative strategies for lung function tests , 2005, European Respiratory Journal.
[373] F. López-Ríos,et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure , 2005, European journal of heart failure.
[374] R. Barst,et al. von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension. , 2005, Chest.
[375] P. Brillet,et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity , 2005, European Respiratory Journal.
[376] Steven H Abman,et al. Effects of long-term bosentan in children with pulmonary arterial hypertension. , 2005, Journal of the American College of Cardiology.
[377] P. Poole‐Wilson,et al. Exercise Intolerance in Adult Congenital Heart Disease: Comparative Severity, Correlates, and Prognostic Implication , 2005, Circulation.
[378] D. Badesch,et al. Ambrisentan therapy for pulmonary arterial hypertension. , 2005, Journal of the American College of Cardiology.
[379] N. Morrell,et al. Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease , 2005, Respiratory research.
[380] M. Humbert,et al. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol , 2005, Thorax.
[381] A. Chaouat,et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[382] A. Boobis,et al. Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension. , 2005, British journal of clinical pharmacology.
[383] J. Wharton,et al. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. , 2005, American journal of respiratory and critical care medicine.
[384] D. Fliser,et al. Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[385] W. Seeger,et al. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[386] M. Humbert,et al. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.
[387] D. Benhamou,et al. Severe Pulmonary Hypertension during Pregnancy: Mode of Delivery and Anesthetic Management of 15 Consecutive Cases , 2005, Anesthesiology.
[388] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[389] H. Mal,et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. , 2005, Chest.
[390] M. de la Morena,et al. Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: a 13-year experience. , 2005, The Journal of thoracic and cardiovascular surgery.
[391] R. Barst,et al. Survival with first-line bosentan in patients with primary pulmonary hypertension , 2005, European Respiratory Journal.
[392] W. Hopkins. The remarkable right ventricle of patients with Eisenmenger syndrome , 2005, Coronary artery disease.
[393] Thomas R Fleming,et al. Surrogate endpoints and FDA's accelerated approval process. , 2005, Health affairs.
[394] E. Fiumana,et al. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells , 2005, Basic Research in Cardiology.
[395] M. Humbert,et al. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. , 2004, American journal of respiratory and critical care medicine.
[396] B. Löwe,et al. Anxiety and Depression in Patients With Pulmonary Hypertension , 2004, Psychosomatic medicine.
[397] W. Seeger,et al. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. , 2004, Journal of the American College of Cardiology.
[398] M. Humbert,et al. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2 , 2004, European Respiratory Journal.
[399] M. Humbert,et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. , 2004, AJR. American journal of roentgenology.
[400] A. Torbicki,et al. Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[401] M. Humbert,et al. Pathologic assessment of vasculopathies in pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[402] M. Humbert,et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[403] Paolo Prandoni,et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.
[404] C. Strassburg,et al. Portopulmonary hypertension and hepatopulmonary syndrome , 2004, The Lancet.
[405] B. Raju,et al. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. , 2004, Journal of the American College of Cardiology.
[406] M. Gladwin,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[407] A. Branzi,et al. The endothelin system in pulmonary arterial hypertension. , 2004, Cardiovascular research.
[408] D. Tsikas,et al. Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans , 2004, Circulation.
[409] C. Denton,et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach , 2003, Annals of the rheumatic diseases.
[410] E. Fadel,et al. Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease , 2003, Circulation.
[411] A. Torbicki,et al. Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension , 2003, Circulation.
[412] K. Wasserman,et al. Beraprost therapy for pulmonary arterial hypertension. , 2003, Journal of the American College of Cardiology.
[413] M. Humbert,et al. Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. , 2003, American journal of respiratory and critical care medicine.
[414] H. Kauczor,et al. Value of contrast-enhanced MR angiography and helical CT angiography in chronic thromboembolic pulmonary hypertension , 2003, European Radiology.
[415] R. Barst,et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension , 2003, Clinical pharmacology and therapeutics.
[416] R. Naeije. Hepatopulmonary syndrome and portopulmonary hypertension. , 2003, Swiss medical weekly.
[417] J. E. Hansen,et al. Pulmonary function in primary pulmonary hypertension. , 2003, Journal of the American College of Cardiology.
[418] M. Sutton,et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. , 2003, American journal of respiratory and critical care medicine.
[419] T. Medsger,et al. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. , 2003, Arthritis and rheumatism.
[420] A. Cohen-Solal,et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study , 2003, Hepatology.
[421] R. Hetzer,et al. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation. , 2003, European heart journal.
[422] A. Branzi,et al. Prostanoids for Pulmonary Arterial Hypertension , 2003, American journal of respiratory medicine : drugs, devices, and other interventions.
[423] R. Favaloro,et al. Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[424] A. Shillington,et al. Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy , 2002, Circulation.
[425] T. Williams,et al. Treatment of Primary Pulmonary Hypertension , 2002 .
[426] Gilles Garcia,et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. , 2002, Journal of the American College of Cardiology.
[427] W. Seeger,et al. Inhaled iloprost for severe pulmonary hypertension. , 2002, The New England journal of medicine.
[428] R. Hetzer,et al. Assessment of Survival in Patients With Primary Pulmonary Hypertension: Importance of Cardiopulmonary Exercise Testing , 2002, Circulation.
[429] S. Keshavjee,et al. Heart-lung or lung transplantation for Eisenmenger syndrome. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[430] M. Humbert,et al. CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension , 2002 .
[431] M. Humbert,et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. , 2002, Journal of the American College of Cardiology.
[432] G. Koch,et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.
[433] R. Barst,et al. Bosentan therapy for pulmonary arterial hypertension. , 2002, The New England journal of medicine.
[434] S. Rich,et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.
[435] M. Humbert,et al. Chemokine RANTES in severe pulmonary arterial hypertension. , 2002, American journal of respiratory and critical care medicine.
[436] M. Rubenfire,et al. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. , 2002, American journal of respiratory and critical care medicine.
[437] R. Speich,et al. Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[438] J. Cohn. Optimal diuretic therapy for heart failure. , 2001, The American journal of medicine.
[439] J. Sandoval,et al. Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. , 2001, American journal of respiratory and critical care medicine.
[440] R. Ewert,et al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. , 2001, Chest.
[441] D. Badesch,et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study , 2001, The Lancet.
[442] J. Cigarroa,et al. Relation of pulmonary arterial diastolic and mean pulmonary arterial wedge pressures in patients with and without pulmonary hypertension. , 2001, The American journal of cardiology.
[443] M. Humbert,et al. Pathobiology of pulmonary hypertension. The role of platelets and thrombosis. , 2001, Clinics in chest medicine.
[444] A. Arroliga,et al. Nocturnal hypoxemia is common in primary pulmonary hypertension. , 2001, Chest.
[445] J. E. Hansen,et al. Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension , 2001, Circulation.
[446] A. Chaouat,et al. "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.
[447] M. Rubenfire,et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. , 2001, The European respiratory journal.
[448] N. Wald. The definition of screening , 2001, Journal of medical screening.
[449] K. Bremme,et al. Cesarean section under epidural ropivacaine 0.75% in a parturient with severe pulmonary hypertension , 2001, Acta anaesthesiologica Scandinavica.
[450] J. Feinstein,et al. Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension , 2001, Circulation.
[451] L. Tavazzi,et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.
[452] J. Mandel,et al. Pulmonary veno-occlusive disease. , 2000, American journal of respiratory and critical care medicine.
[453] W. Colucci,et al. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. , 2000, Circulation.
[454] K. Kangawa,et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. , 2000, Circulation.
[455] R. Wiesner,et al. Pulmonary hemodynamics and perioperative cardiopulmonary‐related mortality in patients with portopulmonary hypertension undergoing liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[456] Stuart Rich,et al. Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease , 2000, Annals of Internal Medicine.
[457] W. Seeger,et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. , 2000, Journal of the American College of Cardiology.
[458] R. Wiesner,et al. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension , 1999, Hepatology.
[459] M. Uematsu,et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. , 1999, American journal of respiratory and critical care medicine.
[460] J. Hohlfeld,et al. Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. , 1999, American journal of respiratory and critical care medicine.
[461] Thomas Albrecht,et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent , 1999, The Lancet.
[462] R. Barst,et al. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. , 1999, Circulation.
[463] G. Maislin,et al. Vasodilator therapy for primary pulmonary hypertension in children. , 1999, Circulation.
[464] M. Hoeper,et al. Plasma coagulation profiles in patients with severe primary pulmonary hypertension. , 1998, The European respiratory journal.
[465] P. Presbitero,et al. Eisenmenger syndrome. Factors relating to deterioration and death. , 1998, European heart journal.
[466] S. Rich,et al. The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. , 1998, Chest.
[467] L. Sharples,et al. Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension , 1998, Heart.
[468] J. Sandoval,et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. , 1998, Journal of the American College of Cardiology.
[469] R. Kuzo,et al. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group. , 1998, Chest.
[470] M. Humbert,et al. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis. , 1998, American journal of respiratory and critical care medicine.
[471] C. Howell,et al. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. , 1998, Transplantation.
[472] S. Lévy,et al. Long-term effects of cicletanine on secondary pulmonary hypertension. , 1996, Journal of cardiovascular pharmacology.
[473] S. Swensen,et al. Mosaic pattern of lung attenuation on CT scans: frequency among patients with pulmonary artery hypertension of different causes. , 1997, AJR. American journal of roentgenology.
[474] C. Howell,et al. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. , 1997, Transplantation.
[475] J. Murray,et al. Anesthetic management and outcome following noncardiac surgery in nonparturients with Eisenmenger's physiology. , 1996, Journal of clinical anesthesia.
[476] R. Wiesner,et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. , 1996, Mayo Clinic proceedings.
[477] J. Barberà,et al. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease , 1996, The Lancet.
[478] B. Groves,et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.
[479] E. Trulock,et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[480] C. Benjamin,et al. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades. , 1995, Molecular pharmacology.
[481] A Giaid,et al. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.
[482] M. Humbert,et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.
[483] A. Chaouat,et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. , 1995, Chest.
[484] A. Denjean,et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. , 1995, American journal of respiratory and critical care medicine.
[485] A. Branzi,et al. Role of pharmacologic tests in the treatment of primary pulmonary hypertension. , 1995, The American journal of cardiology.
[486] S. Rich,et al. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension. , 1995, Chest.
[487] K. Huber,et al. Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension. , 1994, American journal of respiratory and critical care medicine.
[488] D. Stewart,et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.
[489] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[490] J. Moller,et al. Late results (30 to 35 years) after operative closure of isolated ventricular septal defect from 1954 to 1960. , 1991, The American journal of cardiology.
[491] T. Evans,et al. Adenosine as a Vasodilator in Primary Pulmonary Hypertension , 1991, Circulation.
[492] D. Stewart,et al. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? , 1991, Annals of internal medicine.
[493] D. Moodie,et al. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. , 1991, Journal of the American College of Cardiology.
[494] J. H. Diehl,et al. Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol): Results of a Randomized Trial , 1990 .
[495] A. Peacock. Pulmonary hypertension due to chronic hypoxia. , 1990, BMJ.
[496] J. Barberà,et al. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. , 1990, Chest.
[497] J. Rouleau,et al. Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension. , 1988, Annals of internal medicine.
[498] E H Bergofsky,et al. Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.
[499] W. Mckenna,et al. Echocardiographic measurement of the normal adult right ventricle , 1986 .
[500] G. Gregoratos,et al. Fiberoptic angioscopy: role in the diagnosis of chronic pulmonary arterial obstruction. , 1985, Annals of internal medicine.
[501] E. Weitzenblum,et al. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. , 1985, The American review of respiratory disease.
[502] V. Fuster,et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.
[503] G. Simonneau,et al. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. , 1981, The New England journal of medicine.
[504] M. Gee,et al. Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep. , 1981, The American journal of physiology.